Market Overview

Shares of ImmunoGen Tick Lower Following Midday Leerink Downgrade; Rally to Session Highs As Stock Price Bounces Over $6.30/$6.40 Levels


Latest Ratings for IMGN

Aug 2017Canaccord GenuityMaintainsBuy
Jul 2017Morgan StanleyMaintainsUnderweight
Jul 2017RBC CapitalUpgradesSector PerformOutperform

View More Analyst Ratings for IMGN
View the Latest Analyst Ratings

Posted-In: News Downgrades Technicals Analyst Ratings Trading Ideas


Related Articles (IMGN)

Partner Center